2007
DOI: 10.1016/j.jsbmb.2007.05.025
|View full text |Cite
|
Sign up to set email alerts
|

Aromatase inhibitors in ovarian stimulation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

2
32
0
1

Year Published

2008
2008
2020
2020

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 56 publications
(35 citation statements)
references
References 36 publications
(32 reference statements)
2
32
0
1
Order By: Relevance
“…The blockade of conversion of androgens to estrogens (E) leads to a reduction of serum E levels and suppression of E negative feedback in the brain. Aromatase inhibitors also increase the intrafollicular androgen concentration with a concomitant increase in ovarian follicular FSH receptors (25).…”
mentioning
confidence: 99%
“…The blockade of conversion of androgens to estrogens (E) leads to a reduction of serum E levels and suppression of E negative feedback in the brain. Aromatase inhibitors also increase the intrafollicular androgen concentration with a concomitant increase in ovarian follicular FSH receptors (25).…”
mentioning
confidence: 99%
“…Letrozole, on the other hand has a shorter duration of action as it does not deplete the oestrogen receptors. Also the shorter half-life of 45 hours helps to minimise the duration of FSH rise [11]. These properties of letrozole would minimise the interruption of the 'FSH threshold' and the 'FSH window' that is seen in physiological states thus preventing multiple follicle development.…”
Section: Discussionmentioning
confidence: 99%
“…Clomiphene is a selective estrogen receptor modulator that blocks the feedback inhibition of estradiol at the level of the hypothalamus, thus increasing pituitary release of both LH and folliclestimulating hormone (5,21). In addition, clomiphene decreases the conversion of androgen substrate to estrogen by aromatase inhibition (22). It is this ability to block estrogen that leads to its postcycle use by bodybuilders to reduce the development of gynecomastia after self-administration of androgen drugs.…”
Section: Discussionmentioning
confidence: 99%